Several studies have confirmed the overexpression of BACE1, encoding for β-secretase or β-site amyloid precursor protein cleaving enzyme 1 (BACE1), in brain tissue samples obtained from AD patients, together with other hallmarks of AD pathology [44,45,46]. This evidence concerns the gene BACE1 and Alzheimer disease.